Try a new search

Format these results:

Searched for:

in-biosketch:true

person:yazicy01

Total Results:

429


Who decides if research will be published: Authors or sponsors? [Letter]

Yazici, Yusuf
PMID: 24757091
ISSN: 2151-464x
CID: 898902

Two-Year Results from the AMPLE Trial: Low Disease Activity and Association Between Remission and Changes in Physical Function and Radiographic Outcomes with Subcutaneous Abatacept or Adalimumab [Meeting Abstract]

Fleischmann, Roy; Schiff, Michael; Weinblatt, Michael; Maldonado, Michael; Massarotti, Elena; Yazici, Yusuf
ISI:000338923700102
ISSN: 1499-2752
CID: 2734122

Behcet Syndrome Manifestations and Activity in the United States versus Turkey - A Cross-sectional Cohort Comparison

Sibley, Cailin; Yazici, Yusuf; Tascilar, Koray; Khan, Nafiz; Bata, Yasmin; Yazici, Hasan; Goldbach-Mansky, Raphaela; Hatemi, Gulen
OBJECTIVE: To compare clinical manifestations and activity of Behcet syndrome (BS) in the United States versus Turkey using validated outcome measures. METHODS: Consecutive patients with BS from the US National Institutes of Health (NIH), New York University, and the University of Istanbul were evaluated. Disease activity was measured using the Behcet's Syndrome Activity Scale (BSAS) and the Behcet's Disease Current Activity Form (BDCAF) with quality of life measured by the Behcet Disease Quality of Life (BDQOL) form. One-way ANOVA, t-tests, and multivariate regression analyses were performed. RESULTS: Mean age did not differ between sites; however, more women were seen in the United States versus in Turkey (p < 0.001), and disease duration was longer in the United States (p = 0.02). Organ manifestations were similar for oral and genital ulcers, skin disease, arthralgia, eye disease, and thrombosis. However, more gastrointestinal (p < 0.001) and neurologic disease (p = 0.003) was seen in the United States. BSAS and BDCAF scores were worse in the United States compared to Turkey (p = 0.013 and < 0.001, respectively). Worse mean BDQOL scores were observed at the NIH compared to Istanbul (not significant). Multivariable regression models showed worse scores in ethnically atypical patients for BSAS and BDCAF (p = 0.04 and p = 0.001), American patients for BDCAF (p = 0.01), older age for BDCAF (p = 0.005), and women for BDQOL (p = 0.01). CONCLUSION: Demographic and clinical manifestations of BS differ between sites with higher disease activity in the United States compared to Turkey. Referral patterns, age, sex, ethnicity, and country of origin may be important in these differences. These observations raise the question of whether pathogenic mechanisms differ in Turkish and American patients.
PMCID:4565792
PMID: 24931953
ISSN: 0315-162x
CID: 1036592

There was less self-critique among basic than in clinical science articles in three rheumatology journals

Yazici, Hasan; Gogus, Feride; Esen, Fehim; Yazici, Yusuf
OBJECTIVES: There is concern that self-critique with authors acknowledging limitations of their work is not given due importance in scientific articles. We had the impression that this was more true for articles in basic compared with clinical science. We thus surveyed for the presence of self-critique in the discussion sections of the original articles in three rheumatology journals with attention to differences between the basic and the clinical science articles. STUDY DESIGN AND SETTING: The discussion sections of the original articles in January, May, and September 2012 issues of Annals of the Rheumatic Diseases, Arthritis and Rheumatism, and Rheumatology (Oxford) were surveyed (n = 223) after classifying each article as mainly related to clinical or basic science. The discussion sections were electronically scanned by two observers for the presence of the root word "limit" or its derivatives who also read each discussion section for the presence of any limitations otherwise voiced. RESULTS: A limitation discussion in any form was present in only 19 (20.2%) or 29 (30.1%) of 94 basic science vs. 95 (73.6%) or 107 (82.3%) of 129 clinical science articles (P < 0.0001 for either observer). CONCLUSION: Self-critique, especially lacking in basic science articles, should be given due attention.
PMID: 24439068
ISSN: 0895-4356
CID: 783702

Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases is associated with 5 MDHAQ scores not found on the HAQ

Castrejon, Isabel; Yazici, Yusuf; Samuels, Jonathan; Luta, George; Pincus, Theodore
Objective: To analyze discordance between global estimates by patients (PATGL) and their physicians (DOCGL) according to demographic and self-report variables on a multidimensional health assessment questionnaire (MDHAQ), in patients with many rheumatic diseases seen in usual care. Methods: Each patient completes an MDHAQ at each visit, which includes scores for physical function, pain and PATGL, each found on the HAQ, and scores for sleep quality, anxiety, depression, self-report joint count and fatigue, which are not found on the HAQ. A random visit of 980 patients with any rheumatic diagnosis was analyzed in 3 categories: PATGL=DOCGL (within 2/10 units); PATGL>DOCGL (by >/=2/10 units); DOCGL>PATGL (by >/=2/10 units), using descriptive statistics and multinomial logistic regression models. Results: Patients included 145 with rheumatoid arthritis, 57 systemic lupus erythematosus, 173 osteoarthritis, 348 other inflammatory, and 257 other non-inflammatory diseases. Overall, PATGL=DOCGL in 509 (52%), PATGL>DOCGL in 371 (38%) and DOCGL>PATGL in 100 (10%). PATGL>DOCGL was associated significantly with older age, female gender, low formal education, Hispanic ethnicity, not working, high MDHAQ physical function and pain, and high scores for fatigue, poor sleep, anxiety, depression, and self-report joint count, not available on the HAQ. Pain and fatigue were significant in a final multinomial logistic regression; the other variables may raise awareness of discordance to clinicians. Conclusions: Global estimates of patients indicated significantly poorer status than estimates of their physicians in 38% of 980 patients with rheumatic conditions, and were associated with demographic and MDHAQ scores, 5 of which are not available on the HAQ. (c) 2013 American College of Rheumatology.
PMID: 24302706
ISSN: 2151-464x
CID: 789942

ASSOCIATION OF RADIOGRAPHIC OUTCOMES WITH LOW DISEASE ACTIVITY AND REMISSION AND SUSTAINABILITY OF RESPONSE WITH SUBCUTANEOUS ABATACEPT OR ADALIMUMAB: 2-YEAR RESULTS FROM THE AMPLE TRIAL [Meeting Abstract]

Fleischmann, R; Schiff, M; Weinblatt, M; Maldonado, M; Massarotti, E; Fay, J; Yazici, Y
ISI:000346919802137
ISSN: 1468-2060
CID: 1598932

GENDER DIFFERENCES IN DISEASE ACTIVITY IN A PSORIATIC ARTHRITIS ROUTINE CARE COHORT [Meeting Abstract]

Reddy, SM; Scher, U; Swearingen, CJ; Yazici, Y
ISI:000346919804138
ISSN: 1468-2060
CID: 1599062

ASSESSMENT OF EXERCISE STATUS IN ROUTINE CARE USING MDHAQ: EVIDENCE THAT INITIATING EXERCISE IS ASSOCIATED WITH SUBSTANTIALLY BETTER OUTCOMES THAN NO EXERCISE [Meeting Abstract]

Castrejon, I; Celik, S; Pincus, T; Yazici, Y
ISI:000346919802294
ISSN: 1468-2060
CID: 1598982

A PATIENT REPORTED OUTCOME MEASURES-BASED COMPOSITE INDEX (RAPID3) FOR THE ASSESSMENT OF DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS [Meeting Abstract]

Cinar, M; Yilmaz, S; Cinar, FI; Koca, SS; Erdem, H; Pay, S; Dinc, A; Yazici, Y; Simsek, I
ISI:000346919801106
ISSN: 1468-2060
CID: 1598862

RANDOMIZATION TO PATIENT-REPORTED RAPID3 VERSUS PHYSICIAN-BASED CDAI TOOLS FOR PREDICTION OF TREATMENT RESPONSE AND ASSESSMENT OF PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB PEGOL: RESULTS FROM THE PREDICT STUDY [Meeting Abstract]

Curtis, JR; Churchill, M; Kivitz, A; Samad, A; Gauer, L; Coteur, G; Gervitz, L; Koetse, W; Melin, J; Yazici, Y
ISI:000346919802108
ISSN: 1468-2060
CID: 1598922